Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mesenchymal stem cell therapy in joint disease.

Frank P Barry1

  • 1Osiris Therapeutics Inc., 2001 Aliceanns Street, Baltimore, MD 21231, USA.

Novartis Foundation Symposium
|April 24, 2003
PubMed
Summary

Mesenchymal stem cells from bone marrow can regenerate cartilage and slow joint destruction in osteoarthritis. This adult stem cell therapy offers potential for tissue repair in degenerative joint diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allogenic bone marrow-derived mesenchymal stromal cell-based therapy for patients with chronic low back pain: a prospective, multicentre, randomised placebo controlled trial (RESPINE study).

Annals of the rheumatic diseases·2024
Same author

Application of biomaterials to in vitro pluripotent stem cell disease modeling of the skeletal system.

Journal of materials chemistry. B·2020
Same author

Combinatorial conditioning of adipose derived-mesenchymal stem cells enhances their neurovascular potential: Implications for intervertebral disc degeneration.

JOR spine·2020
Same author

Hypoxia Activates the PTHrP -MEF2C Pathway to Attenuate Hypertrophy in Mesenchymal Stem Cell Derived Cartilage.

Scientific reports·2019
Same author

Developing an automated robotic factory for novel stem cell therapy production.

Regenerative medicine·2016
Same author

Thermoresponsive Substrates Used for the Growth and Controlled Differentiation of Human Mesenchymal Stem Cells.

Macromolecular rapid communications·2015

Area of Science:

  • Regenerative Medicine
  • Orthopedics
  • Stem Cell Biology

Background:

  • Mesenchymal stem cells (MSCs) are multipotent cells capable of differentiating into various connective tissues.
  • Adult stem cells, including MSCs, are crucial for tissue regeneration following injury or disease.
  • Osteoarthritis (OA) is characterized by stem cell depletion, reduced proliferation, and impaired differentiation.

Purpose of the Study:

  • To investigate the potential of mesenchymal stem cell delivery for enhancing cartilage repair in injured knee joints.
  • To evaluate the efficacy of bone marrow-derived MSCs in inhibiting progressive joint destruction associated with osteoarthritis.

Main Methods:

  • Isolation and preparation of mesenchymal stem cells from bone marrow.
  • Development of methods for delivering MSC preparations to the injured knee joint.
  • Assessment of MSC treatment effects on cartilage regeneration and joint destruction in an OA model.

Main Results:

  • Mesenchymal stem cell delivery to the knee joint shows potential for stimulating cartilage regeneration.
  • The treatment may retard the progressive joint destruction characteristic of osteoarthritis.
  • Bone marrow-derived MSCs demonstrate therapeutic promise for degenerative joint conditions.

Conclusions:

  • Mesenchymal stem cell therapy offers a promising approach for treating osteoarthritis and other degenerative joint diseases.
  • Targeted delivery of MSCs can potentially restore joint function and inhibit disease progression.
  • Further research into MSC-based therapies is warranted for regenerative medicine applications in orthopedics.

Related Experiment Videos